Phathom Pharmaceuticals Statistics

Total Valuation

PHAT has a market cap or net worth of $219.39 million. The enterprise value is $571.71 million.

Market Cap	219.39M
Enterprise Value	571.71M

Important Dates

The last earnings date was Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

PHAT has 69.65 million shares outstanding. The number of shares has increased by 20.41% in one year.

Current Share Class	69.65M
Shares Outstanding	69.65M
Shares Change (YoY)	+20.41%
Shares Change (QoQ)	+1.30%
Owned by Insiders (%)	3.82%
Owned by Institutions (%)	67.65%
Float	56.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.56
Forward PS	1.57
PB Ratio	-0.65
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.58

Current Ratio	3.58
Quick Ratio	3.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.93

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-55.01%
Return on Invested Capital (ROIC)	-65.47%
Return on Capital Employed (ROCE)	-130.07%
Revenue Per Employee	$191,707
Profits Per Employee	-$809,813
Employee Count	427
Asset Turnover	0.25
Inventory Turnover	4.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.93% in the last 52 weeks. The beta is 0.15, so PHAT's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-66.93%
50-Day Moving Average	4.68
200-Day Moving Average	9.88
Relative Strength Index (RSI)	40.71
Average Volume (20 Days)	2,322,417

Short Selling Information

The latest short interest is 10.92 million, so 15.68% of the outstanding shares have been sold short.

Short Interest	10.92M
Short Previous Month	11.38M
Short % of Shares Out	15.68%
Short % of Float	19.20%
Short Ratio (days to cover)	8.50

Income Statement

In the last 12 months, PHAT had revenue of $81.86 million and -$345.79 million in losses. Loss per share was -$5.19.

Revenue	81.86M
Gross Profit	70.59M
Operating Income	-286.38M
Pretax Income	-297.11M
Net Income	-345.79M
EBITDA	-285.62M
EBIT	-286.38M
Loss Per Share	-$5.19

Full Income Statement

Balance Sheet

The company has $212.32 million in cash and $564.64 million in debt, giving a net cash position of -$352.32 million or -$5.06 per share.

Cash & Cash Equivalents	212.32M
Total Debt	564.64M
Net Cash	-352.32M
Net Cash Per Share	-$5.06
Equity (Book Value)	-338.38M
Book Value Per Share	-4.86
Working Capital	190.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$282.68 million and capital expenditures -$113,000, giving a free cash flow of -$282.79 million.

Operating Cash Flow	-282.68M
Capital Expenditures	-113,000
Free Cash Flow	-282.79M
FCF Per Share	-$4.06

Full Cash Flow Statement

Margins

Gross Margin	86.23%
Operating Margin	-349.84%
Pretax Margin	-422.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHAT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.41%
Shareholder Yield	-20.41%
Earnings Yield	-157.61%
FCF Yield	-128.90%

Analyst Forecast

The average price target for PHAT is $17.80, which is 465.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.80
Price Target Difference	465.08%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	78.22%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PHAT has an Altman Z-Score of -7.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.96
Piotroski F-Score	3